Submission of Revised BE Study Protocol: CDSCO Group Advises Laurus Labs on Carglumic Acid Dispersible Tablets.

Published Date: 27 Mar 2023

NEW DELHI: Pharmaceutical company Laurus Lab's proposal for clinical trial exemption of Carglumic Acid Dispersible Tablet 200mg rejected, Academic Committee...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

Taking vitamin D daily decreased cancer mortality, according to a study.

4.

Study reveals increase in late-stage breast cancer diagnoses in US

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot